Submission Details
| 510(k) Number | K130703 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 15, 2013 |
| Decision Date | September 12, 2013 |
| Days to Decision | 181 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K130703 is an FDA 510(k) clearance for the VIVORTE BVF. This device is classified as a Filler, Bone Void, Osteoinduction (w/o Human Growth Factor) (Class II — Special Controls, product code MBP).
Submitted by Vivorte, Inc. (Fort Wayne, US). The FDA issued a Cleared decision on September 12, 2013, 181 days after receiving the submission on March 15, 2013.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.
| 510(k) Number | K130703 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 15, 2013 |
| Decision Date | September 12, 2013 |
| Days to Decision | 181 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MBP — Filler, Bone Void, Osteoinduction (w/o Human Growth Factor) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3045 |